Back
West Pharmaceutical Services Vs. Repligen Industry Stock Comparison
Buy
52
WST
West Pharmaceutical Services
Last Price:
344.20
Seasonality Move:
4.5%
Buy
59
RGEN
Repligen
Last Price:
150.59
Seasonality Move:
9.8%
Buy
52
West Pharmaceutical Services (WST)
is a Buy
Is West Pharmaceutical Services a Buy, Sell or Hold?
- The current West Pharmaceutical Services [WST] share price is $327.68. The Score for WST is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- WST is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Repligen (RGEN)
is a Buy
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $148.59. The Score for RGEN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- RGEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
WST Stock Price Chart
What is West Pharmaceutical Services's stock price today?
-
The West Pharmaceutical Services share price today is $327.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WST is experiencing slight buying pressure.
RGEN Stock Price Chart
WST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.47 | Buy |
| Relative Strength Index (14 RSI): | 61.18 | Buy |
| Chaikin Money Flow: | 80013 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (290.38 - 322.58) | Buy |
| Bollinger Bands (100): | (293.51 - 320.79) | Buy |
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.61 | Buy |
| Relative Strength Index (14 RSI): | 58.75 | Buy |
| Chaikin Money Flow: | -339133 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (135.52 - 144.88) | Buy |
| Bollinger Bands (100): | (129.3 - 153.42) | Buy |
WST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 323.36 | Buy |
| 20-day SMA: | 310.43 | Buy |
| 50-day SMA: | 304.39 | Buy |
| 200-day SMA: | 336.57 | Sell |
| 8-day EMA: | 322.88 | Buy |
| 20-day EMA: | 314.53 | Buy |
| 50-day EMA: | 308.52 | Buy |
| 200-day EMA: | 325.23 | Buy |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 142.85 | Buy |
| 20-day SMA: | 140.86 | Buy |
| 50-day SMA: | 141.47 | Buy |
| 200-day SMA: | 158.37 | Sell |
| 8-day EMA: | 142.69 | Buy |
| 20-day EMA: | 141.31 | Buy |
| 50-day EMA: | 142.08 | Buy |
| 200-day EMA: | 151.67 | Sell |
West Pharmaceutical Services Earnings Growth & WST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.46 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.36 per share, and an increase next year of $0.87 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.32 per share.
West Pharmaceutical Services Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Repligen Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||